Aurora Cannabis Inc. (TSE:ACB) Given Average Recommendation of “Sell” by Brokerages

Aurora Cannabis Inc. (TSE:ACB) has been assigned an average recommendation of “Sell” from the eleven ratings firms that are covering the stock, MarketBeat reports. Four analysts have rated the stock with a sell rating and three have given a hold rating to the company. The average 12 month target price among brokerages that have updated their coverage on the stock in the last year is C$9.10.

A number of equities analysts have recently commented on ACB shares. Jefferies Financial Group raised shares of Aurora Cannabis to a “hold” rating and cut their target price for the company from C$9.44 to C$6.78 in a report on Friday, September 3rd. Atb Cap Markets restated an “underperform” rating on shares of Aurora Cannabis in a research note on Friday, July 23rd.

Shares of TSE:ACB traded up C$0.09 during trading hours on Friday, reaching C$8.33. The stock had a trading volume of 509,439 shares, compared to its average volume of 2,790,410. Aurora Cannabis has a 1 year low of C$4.93 and a 1 year high of C$24.10. The firm’s 50 day moving average is C$9.04 and its 200-day moving average is C$10.39. The stock has a market capitalization of C$1.65 billion and a price-to-earnings ratio of -0.50. The company has a debt-to-equity ratio of 22.08, a quick ratio of 4.18 and a current ratio of 5.88.

About Aurora Cannabis

Aurora Cannabis Inc produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution.

Featured Story: Why does the United States have a lingering trade deficit?

Analyst Recommendations for Aurora Cannabis (TSE:ACB)

Receive News & Ratings for Aurora Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aurora Cannabis and related companies with's FREE daily email newsletter.